Sado Mitsuhiro, Park Sunre, Ninomiya Akira, Sato Yasuko, Fujisawa Daisuke, Shirahase Joichiro, Mimura Masaru
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Center for Stress Research, Keio University, Tokyo, Japan.
BMC Res Notes. 2018 Sep 6;11(1):653. doi: 10.1186/s13104-018-3744-4.
Mindfulness-based cognitive therapy (MBCT) could be a treatment option for anxiety disorders. Although its effectiveness under conditions of low pharmacotherapy rates has been demonstrated, its effectiveness under condition of high pharmacotherapy rate is still unknown. The aim of the study was to evaluate effectiveness of MBCT under the context of high pharmacotherapy rates.
A single arm with pre-post comparison design was adopted. Those who had any diagnosis of anxiety disorders, between the ages of 20 and 74, were included. Participants attended 8 weekly 2-hour-long sessions followed by 2 monthly boosters. Evaluation was conducted at baseline, in the middle, at end of the intervention, and at follow-up. The State-Trait Anxiety Inventory (STAI)-state was set as the primary outcome. Pre-post analyses with mixed-effect models repeated measures were conducted. Fourteen patients were involved. The mean age was 45.0, and 71.4% were female. The mean change in the STAI-state at every point showed statistically significant improvement. The STAI-trait also showed improvement at a high significance level from the very early stages. The participants showed significant improvement at least one point in some other secondary outcomes. Trial registration Retrospectively registered at the University Hospital Medical Information Network on 1st August 2013 (ID: UMIN000011347).
基于正念的认知疗法(MBCT)可能是焦虑症的一种治疗选择。尽管已证明其在低药物治疗率情况下的有效性,但其在高药物治疗率情况下的有效性仍未知。本研究的目的是评估在高药物治疗率背景下MBCT的有效性。
采用单组前后比较设计。纳入年龄在20至74岁之间、被诊断患有任何焦虑症的患者。参与者参加为期8周、每周2小时的课程,随后是每月2次的强化课程。在基线、干预中期、干预结束时和随访时进行评估。将状态-特质焦虑量表(STAI)-状态设定为主要结局。采用混合效应模型重复测量进行前后分析。共纳入14名患者。平均年龄为45.0岁,71.4%为女性。STAI-状态在各时间点的平均变化显示出统计学上的显著改善。STAI-特质从早期阶段就显示出高度显著的改善。参与者在一些其他次要结局中至少有一项显示出显著改善。试验注册:于2013年8月1日在大学医院医学信息网络进行回顾性注册(编号:UMIN000011347)。